Please login to the form below

Not currently logged in
Email:
Password:

Edelman strengthens public affairs business

Brian Ellner was senior strategist behind New York’s marriage equality campaign
Edelman Brian Ellner

Edelmen has recruited an executive vice president and group head of public affairs.

Brian Ellner will lead Edelman's 35-strong New York public affairs group, reporting to Ron Guirguis, managing director of Edelman New York's corporate and public affairs practice.

Ellner was the senior strategist for the Human Rights Campaign's successful effort to win marriage equality in New York in 2011. Prior to that, he was a senior aide in the administration of Mayor Bloomberg, and has been a litigation associate at Paul Weiss and a litigation counsel at O'Melveny & Myers.

“Brian is an exciting addition to our team in New York and further demonstrates the firm's commitment to investing in and growing the public affairs practice,” said Guirguis.

“He's a proven leader who has successfully managed major public affairs campaigns in the city, the state and nationally.”

Ellner said he was thrilled to be joining at such an exciting time for New York.

“Edelman has set the gold standard for independence, creativity and digital innovation and I'm looking forward to being a part of an exceptionally talented and well-connected global public affairs team to help our clients navigate my hometown”, he added.

Edelman New York's corporate and public affairs practice is home to more than 170 professionals in public affairs, corporate communications, social purpose, employee engagement, technology and management consulting.

28th November 2013

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics